MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
about
The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapyMicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tuneMiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progressionGenomic and epigenomic landscapes of adult de novo acute myeloid leukemia.MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid LeukaemiamiR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.MiR-99a may serve as a potential oncogene in pediatric myeloid leukemiaIdentification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia.MicroRNA-424 is down-regulated in hepatocellular carcinoma and suppresses cell migration and invasion through c-Myb.Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia.Diverse functions of miR-125 family in different cell contexts.Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia.Reduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemiaMicroRNAs as biomarkers in leukemia.The up-regulation of miR-199b-5p in erythroid differentiation is associated with GATA-1 and NF-E2.The pivotal role of microRNA-155 in the control of cancer.MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.Transfection of Kasumi-1 cells with a new type of polymer carriers loaded with miR-155 and antago-miR-155.MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation.microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta.Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells---Cdc2 activity is up-regulated by targeting WEE1.Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia.miR-155 is associated with the leukemogenic potential of the class IV granulocyte colony-stimulating factor receptor in CD34⁺ progenitor cells.Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase.Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis.A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma.MiR-424 regulates monocytic differentiation of human leukemia U937 cells by directly targeting CDX2.MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.Oncogenic role of microRNA-155 in mycosis fungoides: an in vitro and xenograft mouse model study.miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development.
P2860
Q26778301-FB5C9835-02F6-4B30-B3F4-204DD1828955Q27013740-2FCD5941-7D2B-4F29-A2D0-AF0FB258CBB0Q28393361-3515C4CE-545B-4B2A-A2E2-3A8EE12B0737Q29615735-C0CDD9A2-6180-4CFC-8742-D5DBC84929FCQ33612847-57B1317B-309D-4FA6-AED4-8546C4A43F04Q33872395-69F36820-9C3D-4E6E-B422-6946FC0406ABQ34251541-DE5FF08E-9A8F-45A0-B18E-5E6249E8C87CQ34599349-F797CB75-BABD-4462-9F16-FF44A3A4D06DQ35133520-EFA28B85-D13B-495F-AD72-E662FB688FCDQ35745087-D2D14EB0-7652-4E83-9BD0-2312D3BF9E98Q36594402-1B6C1699-751A-4322-8A34-32D2F6E04FECQ36758390-C3E25141-E790-448F-9BCC-7C6FE129F5E2Q36949308-1AFDB1F9-73A4-4D37-AEB8-8A679ADC8916Q37043773-EF13A916-BEDA-4A91-A77D-44BA6CE002A1Q37671235-7C8630B7-ED1F-4223-9CB6-4537386D1B48Q38152297-EC6F155C-9B52-41AD-BF3E-915D96C6E4B7Q38252974-B7D263D4-97E7-41C3-AA0D-E0488AB05224Q38316665-37203929-5E3A-425E-BB16-CC1A37B0D541Q38784189-B8FC4685-B784-4240-9453-DF200063463CQ38998609-A7C6D03C-1820-47E9-8D76-35D5E42DE319Q39137856-08243B4E-F2C6-454B-9242-0344325B3952Q39292054-96668846-B522-4B3B-9941-C1F7729F7FEEQ39675707-CE4061A6-E452-49CA-BF37-2B412494BDBFQ39908852-C7BC9DDB-9093-4108-9DCB-4370D42359F1Q40364668-C251BF4F-1562-4AFF-B8A0-64937B51847FQ41126817-CC139B74-4FEE-4ACF-8764-2CA5ECD2095EQ41346041-C7B72F67-478F-46FD-AB73-8B9B6EB6AB47Q46980837-E4C9F5F4-0AB5-4CED-859B-9F359838418AQ48104779-22FF52EE-3C1F-47E6-B627-B521F8B9406AQ48167908-FD52AD25-0E60-4AB4-8381-6544F3C31C55Q49544999-BB7941C4-0AAA-4B3F-822E-CB25DCF8D548Q49788568-B4F8AE6C-9800-4FDB-A08F-26171307C5DEQ52587340-1AD981CE-BE2D-4452-82B1-0CF09E4769F7
P2860
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MiR-424 and miR-155 deregulate ...... NPM1 and FLT3 mutation status
@en
type
label
MiR-424 and miR-155 deregulate ...... NPM1 and FLT3 mutation status
@en
prefLabel
MiR-424 and miR-155 deregulate ...... NPM1 and FLT3 mutation status
@en
P2093
P2860
P356
P1476
MiR-424 and miR-155 deregulate ...... NPM1 and FLT3 mutation status
@en
P2093
Claudia Ciardi
Davide Ardiri
Francesco Fazi
Isabella Faraoni
Serena Laterza
P2860
P2888
P356
10.1186/1756-8722-5-26
P577
2012-06-08T00:00:00Z
P5875
P6179
1018073860